vs
Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and Resolute Holdings Management, Inc. (RHLD). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $117.7M, roughly 1.4× Resolute Holdings Management, Inc.). Resolute Holdings Management, Inc. runs the higher net margin — -1.5% vs -82.0%, a 80.5% gap on every dollar of revenue. Resolute Holdings Management, Inc. produced more free cash flow last quarter ($189.2M vs $-36.6M).
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
Resolute Mining Limited is an Australian mining corporation focused on mining operations in Africa. It is currently operating two gold mines: the Syama Gold Mine in Mali and the Mako Gold Mine in Senegal.
PTCT vs RHLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $164.7M | $117.7M |
| Net Profit | $-135.0M | $-1.7M |
| Gross Margin | — | 55.7% |
| Operating Margin | -43.3% | 30.2% |
| Net Margin | -82.0% | -1.5% |
| Revenue YoY | -22.7% | — |
| Net Profit YoY | -104.8% | — |
| EPS (diluted) | $-1.63 | $-0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $164.7M | $117.7M | ||
| Q3 25 | $211.0M | $120.9M | ||
| Q2 25 | $178.9M | $119.6M | ||
| Q1 25 | $1.2B | $103.9M | ||
| Q4 24 | $213.2M | — | ||
| Q3 24 | $196.8M | — | ||
| Q2 24 | $186.7M | — | ||
| Q1 24 | $210.1M | — |
| Q4 25 | $-135.0M | $-1.7M | ||
| Q3 25 | $15.9M | $-231.0K | ||
| Q2 25 | $-64.8M | $-611.0K | ||
| Q1 25 | $866.6M | $-3.4M | ||
| Q4 24 | $-65.9M | — | ||
| Q3 24 | $-106.7M | — | ||
| Q2 24 | $-99.2M | — | ||
| Q1 24 | $-91.6M | — |
| Q4 25 | — | 55.7% | ||
| Q3 25 | — | 59.0% | ||
| Q2 25 | — | 57.5% | ||
| Q1 25 | — | 52.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -43.3% | 30.2% | ||
| Q3 25 | 1.4% | 34.3% | ||
| Q2 25 | -19.5% | 34.0% | ||
| Q1 25 | 82.5% | 24.7% | ||
| Q4 24 | -76.2% | — | ||
| Q3 24 | -27.7% | — | ||
| Q2 24 | -21.5% | — | ||
| Q1 24 | -21.6% | — |
| Q4 25 | -82.0% | -1.5% | ||
| Q3 25 | 7.5% | -0.2% | ||
| Q2 25 | -36.3% | -0.5% | ||
| Q1 25 | 73.7% | -3.2% | ||
| Q4 24 | -30.9% | — | ||
| Q3 24 | -54.2% | — | ||
| Q2 24 | -53.1% | — | ||
| Q1 24 | -43.6% | — |
| Q4 25 | $-1.63 | $-0.20 | ||
| Q3 25 | $0.20 | $-0.03 | ||
| Q2 25 | $-0.83 | $-0.07 | ||
| Q1 25 | $10.04 | $-0.39 | ||
| Q4 24 | $-0.85 | — | ||
| Q3 24 | $-1.39 | — | ||
| Q2 24 | $-1.29 | — | ||
| Q1 24 | $-1.20 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | $205.5M |
| Total DebtLower is stronger | — | $169.8M |
| Stockholders' EquityBook value | $-205.3M | $6.5M |
| Total Assets | $2.9B | $333.4M |
| Debt / EquityLower = less leverage | — | 26.03× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9B | $205.5M | ||
| Q3 25 | $1.7B | $148.0M | ||
| Q2 25 | $2.0B | $99.9M | ||
| Q1 25 | $2.0B | $71.0M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $884.8M | — |
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-205.3M | $6.5M | ||
| Q3 25 | $-155.8M | $10.8M | ||
| Q2 25 | $-206.5M | $9.6M | ||
| Q1 25 | $-185.8M | $8.9M | ||
| Q4 24 | $-1.1B | — | ||
| Q3 24 | $-1.1B | — | ||
| Q2 24 | $-980.2M | — | ||
| Q1 24 | $-893.9M | — |
| Q4 25 | $2.9B | $333.4M | ||
| Q3 25 | $2.6B | $293.2M | ||
| Q2 25 | $2.6B | $253.3M | ||
| Q1 25 | $2.7B | $214.3M | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.9B | — | ||
| Q1 24 | $1.8B | — |
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.3M | $196.1M |
| Free Cash FlowOCF − Capex | $-36.6M | $189.2M |
| FCF MarginFCF / Revenue | -22.3% | 160.8% |
| Capex IntensityCapex / Revenue | 1.4% | 5.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $702.3M | $313.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.3M | $196.1M | ||
| Q3 25 | $-66.3M | $59.6M | ||
| Q2 25 | $-58.3M | $48.9M | ||
| Q1 25 | $870.1M | $18.4M | ||
| Q4 24 | $-30.0M | — | ||
| Q3 24 | $-77.0M | — | ||
| Q2 24 | $-71.5M | — | ||
| Q1 24 | $70.8M | — |
| Q4 25 | $-36.6M | $189.2M | ||
| Q3 25 | $-69.7M | $58.6M | ||
| Q2 25 | $-59.6M | $47.5M | ||
| Q1 25 | $868.4M | $17.8M | ||
| Q4 24 | $-33.8M | — | ||
| Q3 24 | $-77.5M | — | ||
| Q2 24 | $-78.8M | — | ||
| Q1 24 | $61.2M | — |
| Q4 25 | -22.3% | 160.8% | ||
| Q3 25 | -33.1% | 48.5% | ||
| Q2 25 | -33.3% | 39.7% | ||
| Q1 25 | 73.8% | 17.1% | ||
| Q4 24 | -15.8% | — | ||
| Q3 24 | -39.4% | — | ||
| Q2 24 | -42.2% | — | ||
| Q1 24 | 29.1% | — |
| Q4 25 | 1.4% | 5.8% | ||
| Q3 25 | 1.6% | 0.8% | ||
| Q2 25 | 0.7% | 1.2% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 4.0% | — | ||
| Q1 24 | 4.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | -4.17× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.00× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
